GET MORE FROM MEDICINES.
RxAnte delivers analytics-powered solutions and clinical services that enable health plans, care providers, and pharmaceutical manufacturers to realize more value from medicines.
-
Our mission is to improve how medicines are prescribed, taken, and paid for. We do things like:
Help health plans improve Medicare Part D and HEDIS quality measures and avoid medical costs related to medication non-adherence.
Enable care providers to better understand and address barriers to their patients’ medication use.
Inform meaningful, evidence-driven discussions with pharmaceutical manufacturers and health plans about drug performance and contracting.
-
The no-obligation RxAnte Adherence Strategy Report is how top-performing Part D plans design their adherence programs.
Highly accurate performance forecasting. Know where you’ll land on the triple-weighted measures this year.
Program simulations. Learn how many interventions are needed to achieve your adherence goals.
Strategic advisory services. Our experts guide your program strategy.
-
Stars Tool: 2019 CMS Stars Data Now Available
Our interactive tool for health plans has been updated. See Star Ratings comparisons across medication measures and the correlation between them. Filters, sliders, and hover capabilities let you see what you need to succeed against rising cut points.
The Results
Below are a few ways we measure medication performance improvement for our clients:
of Medicare Part D contract measures managed by RxAnte improve year-over-year
in annual savings opportunities identified for a health plan deploying our medical cost savings solution.
adherence improvement among plan members reached using our RxEffect® medication adherence workflow solution.
For Health Plans
Deploy our analytics-powered solutions to improve clinical quality, achieve medical cost savings, and better realize the value of medicines on your member populations.
Tell Me More
For Providers
Drive improvements in shared risk arrangements using our predictive analytics and direct-to-patient interventions to ensure patients’ adherence to their medicines.
Tell Me MoreFor Pharmaceutical Manufacturers
Demonstrate the value of drugs on real-world populations and engage in value-based contracts using our evidence-driven approach and transparent performance measurement analytics.
Tell Me More
Our Interventions
Deploy the right intervention mix across your population to achieve quality and cost objectives.
Tell Me MoreResources & Blog
More Resources
CMS 2021 Star Ratings: What are the industry-level takeaways?
Case Study
This document summarizes various industry trends over time on Part C and D measures using CMS data. Hover over plots for detailed information.
5 Key Takeaways from 2021 Star Ratings
Blog Post
On October 8th, CMS released its 2021 Star Ratings. RxAnte has analyzed performance both for the industry as a whole and within our book of business. Ahead of our more detailed industry analysis to be released in the coming week, we're sharing our 5 key takeaways at a glance.
Achieving SUPD Improvement Despite Increased CMS Cut Points
Blog Post
CMS’s release of the 2021 Star Ratings cut points earlier this month reveals that—once again—RxAnte clients show improvement in adherence measures despite persistently rising cut points. For 2020, 90 percent of RxAnte-managed contracts are on track to improve adherence.
Request More Info
Think RxAnte might be right for your organization? Let’s get in touch.
Let's Get StartedUpcoming Events
More Resources
Virtual AMCP Nexus (Oct. 19-23, 2020)
Event
Visit RxAnte at AMCP Nexus 2020 Virtual on October 19-23, where we'll be available to discuss our solutions for improved medication use, including our latest intervention, Mosaic Pharmacy Service.
Star Ratings Master Class (Dec. 14-15, 2020)
Event
Join RxAnte at the RISE live-streamed virtual master class this December. On December 14th at 2:15pm, Kerri Petrin, VP of Strategy and Business Development at RxAnte, will participate in an interesting discussion around Part D Focus: Getting it Right and Achieving Outcomes.